John R. Pinion II

2018

In 2018, John R. Pinion II earned a total compensation of $1.6M as Chief Quality Officer and Executive Vice President, Translational Sciences at Ultragenyx Pharmaceutical, a 17% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$188,030
Option Awards$728,443
Salary$430,320
Stock Awards$217,935
Other$36,346
Total$1,601,074

Pinion received $728.4K in option awards, accounting for 45% of the total pay in 2018.

Pinion also received $188K in non-equity incentive plan, $430.3K in salary, $217.9K in stock awards and $36.3K in other compensation.

Rankings

In 2018, John R. Pinion II's compensation ranked 6,855th out of 14,244 executives tracked by ExecPay. In other words, Pinion earned more than 51.9% of executives.

ClassificationRankingPercentile
All
6,855
out of 14,244
52nd
Division
Manufacturing
2,626
out of 5,765
54th
Major group
Chemicals And Allied Products
990
out of 2,128
54th
Industry group
Drugs
832
out of 1,817
54th
Industry
Pharmaceutical Preparations
650
out of 1,391
53rd
Source: SEC filing on April 29, 2020.

Pinion's colleagues

We found six more compensation records of executives who worked with John R. Pinion II at Ultragenyx Pharmaceutical in 2018.

2018

Wladimir Hogenhuis

Ultragenyx Pharmaceutical

Chief Operating Officer

2018

Camille Bedrosian

Ultragenyx Pharmaceutical

Chief Medical Officer

2018

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2018

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

2018

Karah Parschauer

Ultragenyx Pharmaceutical

General Counsel

2018

Thomas Kassberg

Ultragenyx Pharmaceutical

Chief Business Officer and Executive Vice President

News

You may also like